"Pharmacovigilance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.
| Descriptor ID |
D060735
|
| MeSH Number(s) |
E05.337.800.600 N06.850.505.636
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacovigilance".
Below are MeSH descriptors whose meaning is more specific than "Pharmacovigilance".
This graph shows the total number of publications written about "Pharmacovigilance" by people in this website by year, and whether "Pharmacovigilance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmacovigilance" by people in Profiles.
-
Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work. Cancer Treat Res. 2022; 184:129-140.
-
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions. PLoS One. 2019; 14(7):e0219521.
-
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leuk Res. 2016 May; 44:61-4.
-
Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. 2011 Nov; 78 Suppl 2:S13-7.